Mediwound Ltd (MDWD)

[midastouch017]

MediWound Announces Closing of Public Offering of Ordinary Shares
MediWound Ltd.

https://finance.yahoo.com/news/mediwound-announces-closing-public-offering-220500886.html

YAVNE, Israel, March 10, 2022 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD) (“MediWound”), a biopharmaceutical company that develops, manufactures and commercializes novel, cost effective, bio-therapeutic solutions for tissue repair and regeneration, today announced that on March 7, 2022 it closed its previously announced underwritten public offering of 5,208,333 ordinary shares at a public offering price of $1.92 per share. The gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, were approximately $10 million. MediWound also granted the underwriters a 30-day option to purchase up to an additional 781,249 ordinary shares at the public offering price, less underwriting discounts and commissions.

Investors consisted of both U.S. and Israeli investors including, Clal Biotechnology Industries Ltd., MediWound’s largest shareholder.

MediWound intends to use the net proceeds from the offering for working capital and other general corporate purposes.

Oppenheimer & Co. Inc. acted as the sole book-running manager for the offering.